Skip to main content
. 2023 Nov 27;130(5):703–715. doi: 10.1038/s41416-023-02502-9

Fig. 3. Rationale for combination therapy in oncology.

Fig. 3

The use of multiple drugs can target the inter-tumoural heterogeneity between patients, intra-tumoural heterogeneity within the same tumour (including the cancer stem cell subpopulation). Multiple drugs also target multiple pathways which may be redundant or compensatory allowing full cessation of proliferation, invasion and metastasis. Created using Biorender, May 2023.